Skip to main content

A gene predicts the risk of bone metastasis in breast cancer

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

The “Diario Médico” newspaper makes reference to the II Applied Biomedicine Prize given by the Valdés-Salas Foundation to Roger Gomis, ICREA researcher and group leader of the “Growth control and cancer metastasis” group at IRB Barcelona. Gomis has been awarded this recognition for his work on the identification of a gene capable of predicting the risk of developing bone metastasis in patients with breast cancer.

Read the article in Diario Médico (in Spanish)

Link to Valdés-Salas Foundation

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).